RENOWNED LEADER AND EDUCATOR IN ROBOTIC CARDIAC BYPASS SURGERY LEVERAGES CARDICA'S C-PORT(R) FLEX-A(R) ANASTOMOSIS SYSTEM IN HIS PRACTICE AND TO EDUCATE CARDIOTHORACIC SURGEONS
Dr. Srivastava pioneered both the da Vinci revascularization (DVR) and
port-only coronary artery bypass (port-only CAB) surgical methods. These
procedures require the creation of fingertip-size openings, or ports, that
allow the surgeon to perform this breakthrough approach to minimally-invasive
beating heart coronary bypass graft (CABG) surgery. These procedures are
performed without the need to stop the heart or the use of a heart-lung
machine. Dr. Srivastava has performed more of these procedures than any other
surgeon in the world. Further, he has demonstrated these innovative
techniques to other cardiothoracic surgeons in
"Having performed more than 300 closed-chest robotic beating heart bypass cases using other technologies, I can say that these manual techniques are dependent upon the skill and experience of the operating surgeon," said Dr. Srivastava. "The C-Port Flex-A system, on the other hand, helps enable cardiothoracic surgeons to successfully perform port-only CAB procedures with reproducible anastomoses and excellent early graft patency results."
He added, "The C-Port Flex-A system provides a consistent, mechanically-governed and repeatable automated attachment of the graft vessel during closed-chest bypass procedures and reduces the anastomosis time associated with port-only robotic surgery. Because the C-Port Flex-A system is enabling the next generation of robotic minimally-invasive cardiac surgery, I expect it will encourage broader adoption of minimally-invasive CABG procedures."
Dr. Srivastava also developed off-pump coronary artery bypass through a
left lateral thoracotomy (thoraCAB), a procedure performed through a three- to
five-inch incision in the side of the chest. This approach is frequently used
for bypass surgery involving more than two vessel grafts. The port-only CAB
and thoraCAB techniques are minimally-invasive procedures that eliminate the
need to make a sternotomy which splits the breastbone (sternum). These
techniques provide several patient benefits, including less scarring, faster
recovery and reduced risk of complications. Dr. Srivastava's approach to
multi-vessel closed-chest surgery was recently featured in USA Today on
The C-Port System Advantage
Cardica's C-Port systems are designed to enable automated, reliable and reproducible connections of blood vessels during CABG surgery. Unlike most hand-sewn anastomoses, Cardica's C-Port systems enable a compliant anastomosis that can expand and contract with blood-flow. The C-Port Flex-A system is designed to deploy staples around the periphery of the anastomosis to help provide leak-proof sealing without the need for additional stitches at either end of the anastomosis. It can be used in either on- or off-pump CABG procedures. The C-Port Flex-A system has a flexible, rather than rigid, shaft and is designed to create compliant anastomoses in vessels as small as one millimeter in internal diameter. Importantly, the flexible shaft is designed to allow surgeons to position the device to create a secure connection even in difficult to reach areas of the heart.
About Cardica
Cardica is a leading provider of automated anastomosis systems for
coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures
with easy-to-use automated systems, Cardica's products provide cardiovascular
surgeons with rapid, reliable and consistently reproducible anastomoses, or
connections of blood vessels, often considered the most critical aspect of the
CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed
in
Forward-Looking Statements
This press release contains forward-looking statements, including, without
limitation, statements related to the potential expanded accessibility of
closed-chest CABG procedures from future use of C-Port Flex-A systems and the
potential of C-Port Flex-A systems in the field of cardiothoracic surgery.
The word "expect" and similar expressions are intended to identify
forward-looking statements. These forward-looking statements are based upon
Cardica's current expectations. Forward-looking statements involve risks and
uncertainties. Cardica's actual results and the timing of events could differ
materially from those anticipated in such forward-looking statements as a
result of these risks and uncertainties, which include, without limitation,
risks associated with the long-term patency of graft vessels connected using
the C-Port Flex-A system, market acceptance of Cardica's C-Port Flex-A system,
manufacturing of the C-Port Flex-A system and its suppliers, and Cardica's
sales, marketing and distribution strategy and capabilities. These and other
risk factors are discussed under "Risk Factors" in Cardica's Quarterly Report
on Form 10-Q for the fiscal quarter ended
SOURCE Cardica, Inc.
